H1N1 influenza among hematological patients: monocentric influenza cases from 2011 to 2016.

Main Article Content

Elisabetta Metafuni
Rosaria Santangelo
Patrizia Chiusolo
Luca Laurenti
Federica Sorà
Sabrina Giammarco
Simona Sica *
(*) Corresponding Author:
Simona Sica | simona.sica@unicatt.it


Downloads month by month

Downloads

Download data is not yet available.

Article Details

Author Biographies

Elisabetta Metafuni, Fondazione Policlinico Agostino Gemelli

MD, Department of Hematology

Rosaria Santangelo, Fondazione Policlinico Agostino Gemelli

MD, Microbiology Department

Patrizia Chiusolo, Fondazione Policlinico Agostino Gemelli

MD, Department of Hematology

Luca Laurenti, Fondazione Policlinico Agostino Gemelli

MD, Hematology Department

Federica Sorà, Fondazione Policlinico Agostino Gemelli

MD, Hematology Department

Sabrina Giammarco, Fondazione Policlinico Agostino Gemelli

MD, Hematology Department

Simona Sica, Fondazione Policlinico Agostino Gemelli

Prof, Hematology Department

References

[1] La Torre G, Mannocci A, Colamesta V, D'Egidio V, Sestili C, Spadea A. Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety. Mediterr J Hematol Infect Dis. 2016 Sep 1;8(1):e2016044. doi: 10.4084/MJHID.2016.044. Review.
[2] Ide Y, Imamura Y, Ohfuji S, Fukushima W, Ide S, Tsutsumi C, Koga M, Maeda K, Hirota Y. Immunogenicity of a monovalent influenza A(H1N1)pdm09 vaccine in patients with hematological malignancies. Hum Vaccin Immunother. 2014;10(8):2387-94. doi: 10.4161/hv.29094.
[3] Cherif H, Höglund M, Pauksens K. Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients. Eur J Haematol. 2013 May;90(5):413-9. doi: 10.1111/ejh.12094. Epub 2013 Mar 18.
[4] Engelhard D, Zakay-Rones Z, Shapira MY, Resnick I, Averbuch D, Grisariu S, Dray L, Djian E, Strauss-Liviatan N, Grotto I, Wolf DG, Or R. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic. Vaccine. 2011 Feb 17;29(9):1777-82. doi: 10.1016/j.vaccine.2010.12.113. Epub 2011 Jan 7.
[5] Lalayanni C, Sirigou A, Iskas M, Smias C, Sakellari I, Anagnostopoulos A. Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome. J Infect. 2010;61(3):270-2. doi: 10.1016/j.jinf.2010.06.013.
[6] Vaccinazione antinfluenzale in Italia. Stagioni 2000-2001/2015-2016. Ministero della Salute.http://www.salute.gov.it/imgs/C_17_tavole_19_allegati_iitemAllegati_0_fileAllegati_itemFile_3_file.pdf
[7] Epicentro. Istituto Superiore di Sanità. Bollettino epidemiologico settimanale delle sindromi influenzali. 1/2015.http://www.epicentro.iss.it/problemi/influenza/FluNews/FluNews_2015-4.pdf
[8] Signorelli C, Odone A, Conversano M, Bonanni P. Deaths after Fluad flu vaccine and the epidemic of panic in Italy. BMJ. 2015;350:h116. doi: 10.1136/bmj.h116.